Bristol-Myers Squibb
Patient Engagement in Health Technology Assessment
Pages
3
Time to read
7 mins
Publication
Language
English
Pages
3
Time to read
7 mins
Publication
Language
English
This document is a summary brief from the Shaping Healthcare Workshop held on November 19, 2024, focusing on the engagement of patient communities in the Health Technology Assessment (HTA) lifecycle in Australia. It outlines the desire for earlier and continuous involvement of patient experts and advocacy groups in processes ranging from clinical trials to regulatory approvals. The brief discusses the slow progress in incorporating patient voices into HTA decision-making and highlights recent recommendations for improving patient engagement. Key themes include access and transparency of information, legal and compliance considerations, and the importance of trust and rules of engagement. The document emphasizes the need for clear communication and accessible information for patient communities, as well as the challenges faced in achieving this transparency. It also addresses the regulatory environment and its impact on patient engagement, aiming to foster a collaborative relationship between stakeholders in the healthcare system.